BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32535011)

  • 1. Neuropeptide Y prolongs non-social memory in a brain region- and receptor-specific way in male mice.
    Kornhuber J; Zoicas I
    Neuropharmacology; 2020 Sep; 175():108199. PubMed ID: 32535011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y Reduces Social Fear in Male Mice: Involvement of Y1 and Y2 Receptors in the Dorsolateral Septum and Central Amygdala.
    Kornhuber J; Zoicas I
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y prolongs non-social memory and differentially affects acquisition, consolidation, and retrieval of non-social and social memory in male mice.
    Kornhuber J; Zoicas I
    Sci Rep; 2017 Jul; 7(1):6821. PubMed ID: 28754895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain Region-Dependent Effects of Neuropeptide Y on Conditioned Social Fear and Anxiety-Like Behavior in Male Mice.
    Kornhuber J; Zoicas I
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valence-dependent effects of neuropeptide Y on the expression of conditioned fear and anxiety-like behavior: Involvement of the bed nucleus of the stria terminalis.
    Kornhuber J; Zoicas I
    Neuropharmacology; 2024 Mar; 246():109847. PubMed ID: 38218578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y reduces expression of social fear via simultaneous activation of Y1 and Y2 receptors.
    Kornhuber J; Zoicas I
    J Psychopharmacol; 2019 Dec; 33(12):1533-1539. PubMed ID: 31328614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of memory processing by neuropeptide Y varies with brain injection site.
    Flood JF; Baker ML; Hernandez EN; Morley JE
    Brain Res; 1989 Nov; 503(1):73-82. PubMed ID: 2611661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant-like effect via Y1 receptor.
    Ishida H; Shirayama Y; Iwata M; Katayama S; Yamamoto A; Kawahara R; Nakagome K
    Hippocampus; 2007; 17(4):271-80. PubMed ID: 17265460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y (NPY) prevents depressive-like behavior, spatial memory deficits and oxidative stress following amyloid-β (Aβ(1-40)) administration in mice.
    dos Santos VV; Santos DB; Lach G; Rodrigues AL; Farina M; De Lima TC; Prediger RD
    Behav Brain Res; 2013 May; 244():107-15. PubMed ID: 23396168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide Y: some viewpoints on a multifaceted peptide in the normal and diseased nervous system.
    Hökfelt T; Broberger C; Zhang X; Diez M; Kopp J; Xu Z; Landry M; Bao L; Schalling M; Koistinaho J; DeArmond SJ; Prusiner S; Gong J; Walsh JH
    Brain Res Brain Res Rev; 1998 May; 26(2-3):154-66. PubMed ID: 9651513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
    Silva AP; Carvalho AP; Carvalho CM; Malva JO
    Neuropharmacology; 2003 Feb; 44(2):282-92. PubMed ID: 12623227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptide Y and glutamatergic mechanisms in the amygdala and ventral hippocampus differentially mediate impaired social behavior in diabetic mice.
    Ueda D; Yonemochi N; Kamata T; Kamei J; Waddington JL; Ikeda H
    Behav Brain Res; 2021 May; 405():113195. PubMed ID: 33617904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors.
    Chu DQ; Cox HM; Costa SK; Herzog H; Brain SD
    Br J Pharmacol; 2003 Sep; 140(2):422-30. PubMed ID: 12970079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological actions of neuropeptide Y and its analogs: new measures for anxiolytic therapy?
    Ehlers CL; Somes C; Lopez A; Kirby D; Rivier JE
    Neuropsychopharmacology; 1997 Jul; 17(1):34-43. PubMed ID: 9194048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of NPY mRNA-expressing cells in the human brain: co-localization with Y2 but not Y1 mRNA in the cerebral cortex, hippocampus, amygdala, and striatum.
    Caberlotto L; Fuxe K; Hurd YL
    J Chem Neuroanat; 2000 Dec; 20(3-4):327-37. PubMed ID: 11207429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NPY Receptors Blockade Prevents Anticonvulsant Action of Ghrelin in the Hippocampus of Rat.
    Ghahramanian Golzar M; Babri S; Ataie Z; Ebrahimi H; Mirzaie F; Mohaddes G
    Adv Pharm Bull; 2013; 3(2):265-71. PubMed ID: 24312846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of memory processing by neuropeptide Y.
    Flood JF; Hernandez EN; Morley JE
    Brain Res; 1987 Sep; 421(1-2):280-90. PubMed ID: 3690274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test.
    Redrobe JP; Dumont Y; Fournier A; Quirion R
    Neuropsychopharmacology; 2002 May; 26(5):615-24. PubMed ID: 11927186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippocampal neuropeptide Y
    Méndez-Couz M; González-Pardo H; Arias JL; Conejo NM
    Neurobiol Learn Mem; 2022 Jan; 187():107561. PubMed ID: 34838984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y modulates effects of bradykinin and prostaglandin E2 on trigeminal nociceptors via activation of the Y1 and Y2 receptors.
    Gibbs JL; Diogenes A; Hargreaves KM
    Br J Pharmacol; 2007 Jan; 150(1):72-9. PubMed ID: 17143304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.